Feasibility and acceptability of a novel telepsychiatry-delivered precision prescribing intervention for anxiety and depression.

Erin O'CallaghanScott SullivanCarina T GuptaHeather G BelangerMirène Winsberg

Published in: BMC psychiatry (2022)

Results suggest that the present intervention may be feasible and acceptable within the assessed population. Exploratory analyses suggest that Brightside's course of treatment, guided by precision recommendations, improved patients' symptoms of anxiety and depression.

Keyphrases

randomized controlled trial
end stage renal disease
ejection fraction
primary care
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
patient reported outcomes
clinical practice
depressive symptoms